Skip to main content
LONA
NASDAQ Life Sciences

Major Shareholder Perceptive Advisors Appoints Managing Director to LeonaBio Board

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$9.75
Mkt Cap
$92.62M
52W Low
$3.6
52W High
$50.74
52W Position info
171% above low
Off High info
81% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LONA has more than doubled off its 52-week low of $3.6.

Summary

Perceptive Advisors, a 19.99% owner, has appointed its Managing Director, Fred Callori, to LeonaBio's board, indicating increased investor oversight and strategic involvement.


Key Events · Ownership and Investor Activity · LONA

  • Board Appointment from Major Shareholder

    Fred Callori, a Partner and Managing Director at Perceptive Advisors, was appointed to LeonaBio's board of directors on May 5, 2026.

  • Significant Investor Influence

    Perceptive Advisors, along with Joseph Edelman, beneficially owns 1,882,370 shares, representing 19.99% of LeonaBio's outstanding common stock.

  • Beneficial Ownership Limitation

    The reporting persons are subject to a 19.99% beneficial ownership limitation, restricting warrant/option exercises that would exceed this threshold without prior notice.

  • No Recent Transactions

    None of the reporting persons have effected any transactions in LeonaBio common stock in the past sixty days.


Analysis · LONA · Life Sciences

Perceptive Advisors, a significant institutional investor holding 19.99% of LeonaBio's common stock, has appointed Fred Callori, a Partner and Managing Director at the firm, to the company's board of directors. This move signals increased active involvement and oversight from a major shareholder, potentially influencing future strategic decisions and corporate governance. While no shares were transacted, the direct board representation suggests a deeper commitment and alignment of interests between the large investor and the company.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LONA was trading at $9.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $92.6M. The 52-week trading range was $3.60 to $50.74. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LONA - Latest Insights

LONA
Sep 22, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.05
Real-time Price: $3.88 info
Change: -$2.17 (-36%) info
Market Cap: $36.556M info
LONA
Aug 31, 2026, 4:31 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $7.92
Real-time Price: $3.88 info
Change: -$4.04 (-51%) info
Market Cap: $36.556M info
LONA
Aug 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.01
Real-time Price: $3.88 info
Change: -$4.13 (-52%) info
Market Cap: $36.556M info
LONA
Aug 14, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $3.88 info
Change: -$4.09 (-51%) info
Market Cap: $36.556M info
LONA
Aug 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.97
Real-time Price: $3.88 info
Change: -$4.09 (-51%) info
Market Cap: $36.556M info